Retatrutide targets three receptors GLP-1, GIP, and glucagon which is why clinics and influencers slapped the name GLP-3 on it
Receptor agonists: Substances, often synthetic, that bind to and activate cell receptors
Combined Protocol Example The following represents a typical 16-week protocol for someone starting both compounds: Tirzepatide: Weekly injection, following standard escalation from 2.5mg to 10mg over 16 weeks HGH: 2 IU upon waking (fasted) daily for weeks 1-4, increasing to 3 IU daily weeks 5-16 Cycle Length: 16-24 weeks, followed by 4-8 week break from HGH (Tirzepatide can continue) Monitoring: Bloodwork at baseline, week 8, and week 16 minimum This conservative approach allows proper adaptation to both compounds while providing meaningful body composition results
Focus on leafy greens, colorful vegetables, and lean proteins, which provide nutrients without the risk of an acute drug-herb interaction